Research field

Immunotherapy Research

Immunotherapy research investigates how to harness, augment, or redirect the immune system to treat diseases—particularly cancer, but also autoimmune disorders, infectious diseases, and transplant rejection. The field has been transformed by two landmark advances: immune checkpoint inhibitors that block CTLA-4, PD-1, or PD-L1 to unleash anti-tumor T cells, and CAR-T cell therapy using engineered T cells expressing chimeric antigen receptors that recognize tumor surface markers. Checkpoint immunotherapy now forms a cornerstone of treatment for melanoma, lung cancer, and many other tumor types; CAR-T therapies have achieved remarkable remissions in blood cancers previously considered untreatable. Beyond oncology, mRNA vaccine platforms validated by COVID-19 vaccines are being retooled for personalized cancer vaccines encoding tumor neoantigens specific to each patient's mutational landscape. Research frontiers include understanding why some patients respond while others do not and overcoming immunosuppressive tumor microenvironments in solid tumors.

Top institutions

Key technologies